Award
NIH Reporter #1UG3NS149390-01
Advancing HD Therapeutics
Recipient
University of Massachusetts Medical School Worcester
Award Amount
$1,038,135.00
Ceiling
$1,038,135.00
Awarded
September 02, 2026
Identifier
1UG3NS149390-01
The award funds research into a trivalent RNA interference therapy designed to silence three Huntington’s disease targets. The project will optimize the system and test its safety and effectiveness in animal models.
Description
Blueprint Neurotherapeutics grant to develop and evaluate a trivalent siRNA system that simultaneously targets three disease-related RNAs in Huntington’s disease.